๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for sickle cell disease

Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography NCT07776444NA1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Carbon Dioxide School Readiness Intervention for Preschool Children With Sickle Cell Disease NCT06367192NA1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: The adapted Kids in Transition to School Intervention, Standard school resources Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) NCT02824471n/a1 site๐Ÿ“ Cleveland University Hospitals Cleveland Medical Center ยท Tests: SCD Group PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] NCT06923111n/a12 sites๐Ÿ“ Hamburg๐Ÿ“ Heidelberg๐Ÿ“ Basildon Nova Laboratories Limited ยท Tests: Xromi A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke NCT05953584Phase 29 sites๐Ÿ“ Raipur๐Ÿ“ Delhi๐Ÿ“ Gujarat Forma Therapeutics, Inc. ยท Tests: Etavopivat, Hydroxyurea Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital Tocilizumab for Acute Chest Syndrome NCT05640271Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Tocilizumab SMYLS Multi-site Trial NCT06035939NA1 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Voice Crisis Alert V2, Electronic educational materials Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait NCT07083531n/a1 site๐Ÿ“ Farmington UConn Health ยท Tests: Healthy volunteers without SCT, Healthy volunteers with SCT Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease NCT07274254Phase 312 sites๐Ÿ“ Bordeaux๐Ÿ“ Bordeaux๐Ÿ“ Lille Nantes University Hospital ยท Tests: Lidocain, Placebo, Standard of care A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia NCT06609226Phase 3107 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Los Angeles Novo Nordisk A/S ยท Tests: Etavopivat A, Etavopivat B, Etavopivat C Serial Assessment of Fertility Experiences NCT07116772n/a3 sites๐Ÿ“ Santo Domingo๐Ÿ“ Kingston๐Ÿ“ Mwanza Children's Hospital Medical Center, Cincinnati Blood Sampling for Research Related to Sickle Cell Disease NCT00542230n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site๐Ÿ“ Heidelberg University Hospital Heidelberg A Long-term Follow-up Study in Patients Who Received BEAM-101 NCT07373639n/a17 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Jacksonville Beam Therapeutics Inc. ยท Tests: Long-Term Follow-up Study of patients who received BEAM-101 Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease NCT03587272Phase 27 sites๐Ÿ“ Washington D.C.๐Ÿ“ Chicago๐Ÿ“ New York Robert Nickel ยท Tests: Alemtuzumab, low dose total body irradiation, Sirolimus A Study of Immune Suppression Treatment for People With Sickle Cell Disease or ฮฒ-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) NCT05736419Phase 26 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Fludarabine, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Rabbit ATG Study of the Role of Genetic Modifiers in Hemoglobinopathies NCT05799118n/a26 sites๐Ÿ“ Boston๐Ÿ“ Luanda๐Ÿ“ Buenos Aires Cyprus Institute of Neurology and Genetics ยท Tests: GWAS Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in Ghana NCT07488091NA1 site๐Ÿ“ Accra University of Ghana Medical School ยท Tests: Multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital. Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype NCT07282210Phase 24 sites๐Ÿ“ Toronto๐Ÿ“ Toronto๐Ÿ“ Montreal Biossil Inc. ยท Tests: Senicapoc, Placebo Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis NCT07188766NA2 sites๐Ÿ“ Dammam๐Ÿ“ Riyadh Imam Abdulrahman Bin Faisal University ยท Tests: Sodium Chloride (NaCl) 0.9 %, Sodium Chloride (NaCl) 0.9 % Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations NCT06418256n/a5 sites๐Ÿ“ Clichy๐Ÿ“ Paris๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Spleen, blood and plasma collection Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders NCT06147414n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Blood sample A Real-World Registry of Chronic Wounds and Ulcers NCT02280733n/a1 site๐Ÿ“ The Woodlands U.S. Wound Registry ยท Tests: Usual care Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA NCT06581900n/a1 site๐Ÿ“ Reims CHU de Reims ยท Tests: Vitamin B12 T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA) NCT05383911NA1 site๐Ÿ“ Wilmington Nemours Children's Clinic ยท Tests: SCD Shared Decision-Making Toolkit for AYAs - including VR, SCD Shared Decision-Making Toolkit for AYAs - without VR Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises NCT06184126NA1 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Virtual Reality Headset and Hand-Held Controllers, Blindfolding and Noise Cancelling A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease NCT04166526n/a1 site๐Ÿ“ Boston Boston Children's Hospital ยท Tests: FDNIRS-DCS, MRI
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy